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Background: Extracellular matrix (ECM) disarray is found in calcific aortic valvular disease (CAVD), yet much remains
to be learned about the role of individual ECM components in valvular interstitial cell (VIC) function and
dysfunction. Previous clinical analyses have shown that calcification is associated with decreased collagen content,
while previous in vitro work has suggested that the presence of collagen attenuates the responsiveness of VICs to
pro-calcific stimuli. The current study uses whole leaflet cultures to examine the contributions of endogenous
collagen in regulating the phenotype and calcification of VICs.
Methods: A “top-down” approach was used to characterize changes in VIC phenotype in response to collagen
alterations in the native 3D environment. Collagen-deficient leaflets were created via enzymatic treatment and
cultured statically for six days in vitro. After culture, leaflets were harvested for analysis of DNA, proliferation,
apoptosis, ECM composition, calcification, and gene/protein expression.
Results: In general, disruption of collagen was associated with increased expression of disease markers by VICs
in whole organ leaflet culture. Compared to intact control leaflets, collagen-deficient leaflets demonstrated increased
VIC proliferation and apoptosis, increased expression of disease-related markers such as alpha-smooth muscle actin,
alkaline phosphatase, and osteocalcin, and an increase in calcification as evidenced by positive von Kossa staining.
Conclusions: These results indicate that disruption of the endogenous collagen structure in aortic valves is sufficient to
stimulate pathological consequences in valve leaflet cultures, thereby highlighting the importance of collagen and the
valve extracellular matrix in general in maintaining homeostasis of the valve phenotype.
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Calcific aortic valve disease (CAVD) is characterized by se-
vere thickening of the valve leaflets, extracellular matrix
(ECM) disarray, and formation of calcified nodules de-
posited in the fibrosa, leading to valve stiffening and
obstructed ventricular outflow [1]. Recent evidence
suggests that this calcification is a cell-mediated, active
process that involves elements of both dystrophic and
ossific calcification, including expression of markers
indicative of either myofibroblast or osteoblast differ-
entiation, respectively [2,3]. There is mounting in vitro
and in vivo evidence that the valve ECM may play a
critical role in mediating these events [4-9]. Although
several studies have highlighted the importance of the* Correspondence: kmasters@wisc.edu
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the mechanical, but also the biological, functions of the
valve [6,7,9-11], the contribution of individual ECM com-
ponents to CAVD etiology is not well understood.
Collagen is the major ECM component of the aortic
valve, comprising approximately 50% of the total valve
ECM composition by dry weight [12]. The most abun-
dant types of collagen found in the aortic valve are type
I (74%), type III (24%) and type V (2%) [13]. Collagen is
mainly found in the fibrosa as interweaving, densely-
packed bundles of fibers oriented circumferentially
[14,15], where it serves to provide mechanical strength
to the valve. The unique interweaving configuration of
the collagen fibrils allows for load resistance and leaflet
expansion during valve closure, and the maintenance of
collagen homeostasis is therefore imperative for proper
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age [16], and this event is accompanied by an increase in
the prevalence of aortic valve calcification [17]. Among
the many phenotypic changes that can occur during
CAVD is the upregulated expression of matrix metallo-
proteinases 1, 3, 9 and 13 (MMP-1, MMP-3, MMP-9
and MMP-13) [18,19], all of which are associated with
collagen degradation [20]. This ultimately results in ex-
tensive disorganization of the collagen fibers in the leaf-
let [21], thus compromising the structural integrity of
the valve. Analysis of explanted calcified valves has
shown that total collagen content in these valves is sig-
nificantly lower than that found in age-matched normal
valves [8]. These findings indicate that, during calcifica-
tion, degradation of collagen exceeds its synthesis. More-
over, this increase in collagen degradation, specifically
collagen type I, occurs in a localized manner around cal-
cific nodules [8]. While this previous work suggests that
collagen deficiency is associated with calcific events, it is
unknown whether this phenomenon is sufficient to initi-
ate further valve or VIC dysfunction.
These studies are complemented by in vitro work
demonstrating that nodule formation by VICs is highly
dependent upon ECM composition; specifically, some
ECM components strongly support the formation of
nodules in VIC cultures, while other ECM components,
such as collagen, appear to inhibit nodule formation [7].
VICs cultured on collagen-coated surfaces have demon-
strated resistance to calcification even after treatment with
pro-calcific stimuli [7]. Together, these findings implicate
VIC-collagen interactions as a crucial element in main-
taining a healthy VIC phenotype, but much remains to be
learned regarding the role of collagen in CAVD etiology.
Therefore, this work studies the importance of VIC-
collagen interactions in the maintenance of a healthy
VIC phenotype. We analyzed the VIC-collagen relation-
ship via a “top-down” approach previously described by
our lab [5] that allowed controlled manipulation of na-
tive ECM composition to characterize VIC phenotype in
response to the introduction of a collagen deficiency in a
native 3D environment. Understanding the individual
contribution of collagen, a major valve ECM component,
to valvular disease may not only help us better under-
stand calcific valve etiology and identify potential targets
for treatment, but also help to inform the design of scaf-
fold materials for tissue-engineered valves.
Methods
Unless otherwise stated, all products are from Sigma-
Aldrich, St. Louis, MO. Data were compared using
ANOVA with Tukey’s HSD post-hoc test, or a student’s
t-test where appropriate, for which statistical significance
was defined as P ≤ 0.05. Data are presented as mean ±
standard deviation.All tissues used in this study were acquired post-
mortem from a commercial slaughterhouse, and were
therefore not subject to institutional animal protocol ap-
proval. The slaughterhouse follows USDA and Humane
Slaughter Act guidelines for care and slaughter of the
swine.
Depletion of collagen from native valve leaflets
The collagen content of native valve leaflets was altered
via targeted enzymatic digestion, similar to previous
work described for hyaluronic acid depletion [5]. Leaflets
were excised from porcine aortic valves (Hormel, Inc.,
Austin, MN) and washed in a solution of Medium 199
(pH 7.4) supplemented with 200 U/ml penicillin and
200 μg/ml streptomycin. This was followed by a 1.5 hour
incubation at 37°C with shaking in a solution of 96 U/mL
collagenase type II (Worthington Biochemical Corp.), while
control leaflets were incubated in wash solution for the
same duration of time. Leaflets were rinsed numerous
times in wash solution, denuded of endothelial cells, cut in
half, and prepared for either Day 0 characterization or
in vitro organ culture as described in subsequent sections.
Untreated native leaflets were used as controls. Endothelial
denudation was confirmed via detection of von Willebrand
factor (rabbit anti-vWF, Dako, Carpinteria, CA) using
standard immunohistochemical techniques.
Validation of targeted collagen depletion method
To validate the effectiveness of collagenase treatment to
selectively remove collagen from native valve leaflets,
Day 0 enzyme-treated leaflets were frozen immediately
following the collagenase treatment, freeze-dried for
72 hours, flash frozen in liquid nitrogen, pulverized,
and incubated in a papain solution (19 U/mg papain
(Worthington Biochemical), 10 mM cysteine in PBE
buffer) overnight at 60°C with shaking. Following di-
gestion, samples were homogenized by vortexing and
used for detection of total collagen, hyaluronic acid
(HA), sulfated glycosaminoglycans (sGAGs), and DNA.
Total collagen was indirectly measured by detecting
the total amount of hydroxyproline in the leaflet digest
[22], wherein hydroxyproline accounts for 13.3% of
total collagen [23]. The amount of sGAG was quanti-
fied by the dimethyl methylene blue (DMMB) assay
and compared against chondroitin sulfate standard so-
lutions as previously reported [24]. The amount of HA
in the samples was determined using a HA quantitative
test kit (Corgenix, Broomfield, CO). Total DNA con-
tent was measured by the Pico Green assay (Invitro-
gen, Carlsbad, CA). All results were normalized to
leaflet dry weight. Swelling ratio of the leaflets was cal-
culated as the leaflet wet weight divided by the leaflet
dry weight. To conduct mechanical testing, enzyme-
treated and control leaflets were cut into 4.5 mm wide
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(Instron Model 5548 MicroTester) to calculate the leaf-
let Young’s modulus, as has been described elsewhere for
the mechanical characterization of heart valves [25]. Test-
ing was performed in an environmental chamber filled
with PBS and held at 37°C. To visualize valve architecture
following collagenase treatment, histological examination
was performed on formalin-fixed leaflets that were em-
bedded in paraffin and cut into 7 μm thick sections.
Sections were stained with Movat’s pentachrome (Poly
Scientific, Bay Shore, NY), and brightfield images were
captured using an Olympus IX51 microscope.In vitro culture of whole leaflets
Untreated and collagenase-treated leaflets were prepared
as described above and statically cultured attached to
non-adhesive silicone bases at 37°C in VIC growth medium
containing 15% FBS. Culture medium was changed every
other day for a period of 6 days. After culture, leaflets
were fixed or digested for analysis of cell proliferation,
apoptosis, or phenotype via methods specified in sub-
sequent sections.Proliferation and apoptosis
Proliferating VICs in cultured leaflets were visualized
and quantified using the Click-It EdU Cell Proliferation
kit (Invitrogen). EdU was added to the media on Day 5
of leaflet culture and incubated overnight. On Day 6,
leaflets were fixed in 10% neutral buffered formalin for
1 hour, embedded in tissue freezing medium, flash fro-
zen, and sectioned into 7 μm slices using a cryostat
(HM 505-E, Microm International GmbH, Walldorf,
Germany). Detection of EdU was achieved by a copper-
catalyzed reaction resulting in fluorescence that was visu-
alized using an Olympus IX51 microscope, and sections
were counterstained with DAPI (1 μg/ml). The number of
actively proliferating cells and total cells in leaflet sections
was quantified using NIH ImageJ Software.
Apoptotic VICs in the leaflets were visualized using
the TUNEL-based ApopTag Red In Situ Apoptosis De-
tection Kit (Millipore, Billerica, MA). After culture, leaf-
lets were fixed in 10% neutral buffered formalin for
1 hour at RT followed by post-fixation in pre-cooled
ethanol:acetic acid solution (2:1) for 5 minutes at -20°C.
Tissue sections were prepared as specified above. After
application of the equilibration buffer, TdT enzyme was
incubated for 1 hour at 37°C. Subsequent TdT detection
was performed by incubating with anti-digoxigenin con-
jugate for 30 minutes at RT. Apoptotic cells in DAPI-
counterstained leaflet sections were visualized using an
Olympus IX51 microscope. The number of apoptotic
cells and total cells in leaflet sections was quantified
using NIH ImageJ Software.Characterization of cell phenotype in leaflets
Histological analysis for markers of a diseased VIC
phenotype was performed on collagen-depleted and con-
trol leaflets after six days of in vitro culture. Leaflets
were fixed in 10% neutral buffered formalin and pre-
pared for sectioning as described above. Tissue sections
were washed four times with diH2O prior to immuno-
histochemical staining for alpha smooth muscle actin
(α-SMA) or alkaline phosphatase (ALP). Sections were
blocked overnight with a 5% BSA solution in PBS at
RT, followed by application of primary antibodies di-
luted in 1% BSA in PBS: anti-α-SMA (mouse, clone
1A4, 5 μg/mL) and anti-ALP (mouse, clone AP-59,
1:1000). After overnight incubation at 4°C, the sections
were rinsed in PBS and reacted with goat anti-mouse
AlexaFluor 488 IgG conjugate (2 μg/mL; Invitrogen)
for 1 hour. The leaflet orientation and region that is
displayed is comparable across all photomicrographs.
Quantification of α-SMA and ALP was performed via
western blotting. Tissue specimens were lysed in a 2%
sodium dodecyl sulfate (SDS) lysis buffer, and the amount
of total protein in the samples was quantified via the Mi-
cro BCA Assay (Pierce, Rockford, IL). Separation of pro-
teins in the lysate was performed by gel electrophoresis
using 4-12% Bis-Tris NuPage Gels (Invitrogen). Blotting
onto a nitrocellulose membrane and subsequent blocking
were performed using standard western blotting tech-
niques. Blot membranes were then incubated with pri-
mary antibodies (anti-α-SMA, anti-ALP, and anti-β-
Tubulin; rabbit, AbCam, Cambridge, MA) for 1.5 hours
at RT with shaking and IRDye-conjugated secondary
antibody (Li-Cor Biotechnology, Lincoln, NE) for 1 hour
at RT with shaking. Infrared fluorescence was detected
and quantified using the Odyssey Infrared Imaging System
(Li-Cor).
Quantification of calcific markers via qRT-PCR
Total RNA was isolated using the RNeasy Mini Kit
(Qiagen, Valencia, CA). After six days of in vitro cul-
ture, leaflets were flash frozen in liquid nitrogen, pul-
verized and lysed as specified by the manufacturer.
Construction of the cDNA was done by reverse tran-
scribing 100 ng of the isolated RNA using the High
Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Carlsbad, California) according to manu-
facturer’s instructions.
Custom TaqMan Gene Expression assays for osteocalcin
(OCN) and bone sialoprotein (BSP), later-stage markers of
osteogenesis, were purchased from Applied Biosystems.
For real-time PCR analysis, 1 μL of the cDNA was com-
bined with 1 μL of TaqMan Gene Assay and TaqMan
Master Mix, as specified by the manufacturer. The PCR
cycling temperatures and times were also specified by the
manufacturer (40 cycles of denaturing at 95°C for
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data were first normalized to GAPdh and then to the
undepleted Day 6 leaflet control using the comparative CT
method (ΔΔ CT).Calcification staining
Tissue mineralization was detected by visualization of
calcium deposition in the sections via von Kossa stain-
ing. Tissue sections were incubated in a 5% silver nitrate
solution for 1 hour under ultraviolet light and counter-
stained with 0.1% nuclear fast red (Acros Organics) for
5 minutes. Calcium deposits were identified in photomi-
crographs by black staining. Calcium content was quan-
tified by performing extraction of Alizarin Red S (ARS)
staining [26]. In brief, leaflets were stained for 1 hour
with ARS, flash frozen in liquid nitrogen and pulverized,
followed by 30 minutes incubation with 10% acetic acid
at room temperature with shaking. After incubation,
samples were heated at 85ºC for 10 minutes. Mineral oil
was added to the solution to avoid evaporation while
heating. Samples were then cooled on ice for 5 minutes
and centrifuged at 20000 × g. The supernatant was
transferred to a new tube and mixed with 10% ammo-
nium hydroxide. Absorbance of the resulting solution
was read at 405 nm on a microplate reader (Synergy HT,
Biotek Instruments).Results
Depletion of collagen from the native ECM
To better understand the role of collagen in regulating
the phenotype and calcification of VICs, we took a “top-
down” approach in which collagen was partially removed
from native aortic valve leaflets via targeted enzymatic
digestion. Although we have previously reported a vari-
ation of this technique [5] to explore the contributions
of individual ECM components to VIC function in a 3D
environment, we first performed validation experiments
to quantify collagen loss and retention of other proper-
ties. Figure 1 demonstrates that this ECM depletion
method is effective in removing solely the target ECM
component from the native leaflet. Specifically, colla-
genase treatment was highly effective in removing
27.2% of the collagen (Figure 1A) without altering
other important leaflet characteristics; namely, the
amounts of HA (Figure 1B) and sulfated GAGs (Figure 1C),
as well as cellularity (Figure 1D), swelling ratio (Figure 1E),
and Young’s Modulus (Figure 1F) did not significantly
differ between untreated and collagenase-treated leaflets
(P > 0.05). Movat’s pentachrome staining also confirmed
retention of cellularity and overall leaflet architecture; the
proteoglycan-rich spongiosa layer (blue) was not noticeably
altered, but diminishment of collagen content (yellow) was
obvious upon collagenase treatment (Figure 1G).Characterization of collagen-deficient leaflet composition
Following confirmation of the feasibility of using a low
concentration of collagenase to preferentially decrease
leaflet collagen content with minimal disruption of other
leaflet ECM components, these altered leaflets were then
used to examine how the loss of collagen from the native
leaflet environment impacted VIC phenotype. After
6 days of in vitro culture, the ECM composition of unde-
pleted leaflets remained similar to the composition of
the Day 0 fresh leaflets (Figure 2; Day 0 average is repre-
sented as dashed line, with gray box representing Day 0
standard deviation), although HA content did decrease
slightly relative to the Day 0 control. Leaflets that had
been subjected to collagenase treatment on Day 0 dem-
onstrated an increase in collagen over the subsequent
6 days of culture such that the collagen content of the
collagenase-treated condition recovered to levels found
in the undepleted Day 0 and Day 6 controls (Figure 2A).
Meanwhile, collagenase-treated leaflets displayed a sig-
nificant decrease in HA and sGAGs after the in vitro
culture period (Figure 2B-C, P < 0.05). The drop in HA
content was particularly notable, resulting in 5-fold less
HA than found in the undepleted control. As shown in
Figure 2D, collagen disruption did not significantly alter
leaflet cellularity from the baseline value obtained for
Day 0 fresh leaflets.
Phenotypic characterization of collagen-deficient leaflets
Characterization of leaflet cultures demonstrated that
the partial removal of collagen from the native leaflet
also had a significant impact on VIC proliferation, apop-
tosis, and phenotype. Collagenase treatment was suffi-
cient to significantly increase both VIC proliferation and
apoptosis in leaflets when compared to the undepleted
control (Figure 3).
Quantification of multiple calcific markers via immu-
nohistochemistry, western blot, and qRT-PCR indicated
that the partial removal of collagen resulted in VIC ex-
pression of markers associated with myofibroblast and
osteoblast activity, both of which are known to contrib-
ute to calcification. Specifically, production of α-SMA,
the hallmark protein indicative of a myofibroblast VIC
phenotype, was significantly increased in collagenase-
treated leaflets (Figure 4). ALP, which is used as an early
marker for osteogenic differentiation, was also signifi-
cantly increased in collagen-depleted leaflets (Figure 5).
Gene expression analysis indicated that later-stage markers
of osteogenesis, OCN and BSP, were also significantly
elevated in collagen-depleted leaflet cultures (Figure 6).
Finally, these phenotypic changes were found to ultim-
ately result in increased mineralization in collagen-
depleted leaflets, as indicated by positive von Kossa
staining (Figure 7A) and significantly increased total



















































































































































Figure 1 Leaflet characterization immediately after collagenase treatment, prior to in vitro organ culture. Quantification of (A) total
collagen, (B) HA, (C) total sGAGs, (D) DNA, (E) swelling ratio, and (F) Young’s Modulus indicated that collagenase-treated leaflets were selectively
depleted of collagen. (G) Movat’s Pentachrome staining indicated depletion of collagen (yellow) in collagenase-treated leaflets, but retention of
other valve components, such as proteoglycans (blue). Scale bar = 400 μm. *P <0.05 compared to undepleted leaflets (no enzyme).
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Collagen is the most abundant ECM protein in the valve
leaflet [14] and has proven attractive as a scaffoldmaterial for valve tissue engineering [27,28]. However,
relatively little is known about the importance of VIC-


































































































Figure 2 After 6 days of in vitro culture, leaflet composition was analyzed via measurement of (A) total collagen, (B) HA, (C) total
sGAGs, and (D) DNA. The dashed line and gray box in each panel represent the mean and standard deviation for the Day 0 (fresh, undepleted
leaflet) control. *P <0.05 compared to undepleted; ^P < 0.05 compared to Day 0 control.
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study investigated the role of native valve collagen con-
tent in regulating VIC phenotype. Our findings suggest
that collagen disruption or deficiency is sufficient to in-
duce VIC activation to a pathological phenotype, with a
subsequent increase in mineralization.
Calcified valves experience a decrease in collagen con-
























Figure 3 After 6 days of in vitro culture, VICs in collagen-deficient lea
and apoptosis. (A) Proliferating cells per total cell number on Day 6, and
percent of no-enzyme control. *P <0.0005 compared to undepleted.nodules. Meanwhile, work by our own lab has shown that
VICs cultured on collagen-coated surfaces did not form
nodules, even after treatment with potent pro-calcific
stimuli [7], suggesting that collagen may act in a ‘protect-
ive’ manner and actively perform functions to inhibit VIC
calcification. Thus, to further investigate the importance
of VIC-collagen interactions in valve calcification, we



























flets exhibited significantly higher levels of both proliferation


































Figure 4 α-SMA expression by VICs in collagen-deficient leaflets
was elevated compared to undepleted leaflets, as evidenced by
(A) immunohistochemical staining for α-SMA on Day 6 and (B)


































Figure 5 ALP expression by VICs in collagen-deficient leaflets
was elevated compared to undepleted leaflets, as evidenced by
(A) immunohistochemical staining for ALP on Day 6 and (B)
western blot for ALP on Day 6. Scale bar = 100 μm. *P < 0.05
compared to undepleted.
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response of VICs to a decrease in native collagen con-
tent. As shown by our results, this method can be tai-
lored to remove from the native environment only the
ECM component of interest (in this case, collagen)
without significantly altering cellularity, tissue me-
chanics, or other ECM proteins. Using this method, we
were able to successfully remove 27% of the total colla-
gen, thus creating collagen-deficient leaflets. VIC via-
bility within the depleted leaflets also remained at the
same level as undepleted controls (not shown), which
was the expected result, as the amount of collagenase
used for depletion is substantially less than what is typ-
ically used to harvest healthy, viable VICs from leaflets
for subsequent in vitro culture.
The partial removal of collagen was effective at indu-
cing both VIC proliferation and apoptosis relative to
undepleted leaflets, which remained relatively quiescent.
VIC apoptosis and proliferation are known to be in-
creased in response to injury and to contribute to valve
pathology [29-32]. Thus, the increase of these two events
upon alteration of ECM content further indicates thatVICs were activated in response to these environmental
changes.
Previous studies by others suggest that, in calcified valves,
changes in the microenvironment, such as collagen damage,
may stimulate a series of events that cause accumulation of
tenascin-C, an ALP upregulator that participates in
mineralization [33]. Our results are consistent with this find-
ing, as depletion of collagen from the valve leaflet led to an
increase in the expression of several disease markers, includ-
ing ALP. Specifically, we observed a significant increase in
the protein expression of ALP and in the mRNA expression
of OCN and BSP, all markers of an osteoblast-like pheno-
type. Production of α-SMA, indicative of a myofibroblast
phenotype, was also upregulated in the collagen-deficient
leaflets. Our mineralization data further demonstrate that
interaction of VICs with collagen is important for the pre-
vention of a diseased state, as disruption of collagen homeo-
stasis was sufficient to increase calcium content in leaflet
cultures. Together, these results suggest that inducing a
collagen-deficient leaflet environment led to the stimulation
of VICs to differentiate into pathological phenotypes, ultim-































Figure 6 Expression of later-stage osteoblastic markers
osteocalcin (OCN) and bone sialoprotein (BSP) in undepleted
vs. collagen-depleted leaflets was measured via RT-PCR after
6 days of in vitro culture; both markers were significantly



























Figure 7 Characterization of leaflet mineralization indicated greater mi
controls. (A) von Kossa staining for mineralization was performed after 6 day
images of Day 6 samples are included to better visualize the differences in sta
leaflets compared to undepleted leaflets after 6 days of culture. Scale ba
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collagen resulted in a dramatic decrease in leaflet HA
content, considering that previous work by our group
has identified VIC-HA interactions as being crucial for
maintenance of a healthy VIC phenotype [5]. In fact, the
elevation of proliferation, apoptosis, ALP, and α-SMA
described herein mirrors findings reported for when
VIC-HA interactions were disrupted via a blocking anti-
body or when leaflets were rendered HA-deficient [5].
The authors have not found this to occur when other
ECM components, such as elastin or chondroitin sulfate,
are depleted (via elastase or chondroitinase, respectively;
see Additional file 1: Figure S1), so this does not appear
to merely be a non-specific result related to leaflet ECM
alteration. These similarities, combined with the fact that
collagen depletion induced an HA deficiency in the
current study, raises the question of whether the pheno-
type results described herein are actually due to disrup-
tions in VIC-HA interactions, with collagen insufficiency
being the event that initiates this cascade of events. The
ability of collagen disruptions to act as a precipitating
event to HA disruption and subsequent phenotypic al-
terations and calcification cannot be confirmed by the
current study, but forms an interesting question toollagenase 
*
Day 6 
neralization of collagen-deficient leaflets compared to undepleted
s of culture; calcium deposits are stained black. Higher magnification
ining between conditions. (B) Calcium content in collagen-deficient
r = 100 μm. *P < 0.05 compared to undepleted.
Rodriguez et al. BMC Cardiovascular Disorders 2014, 14:29 Page 9 of 10
http://www.biomedcentral.com/1471-2261/14/29investigate in future work to better understand ECM dy-
namics in valve dysfunction.
Finally, it is important to note one significant limita-
tion in this study, which is that the experiments were
performed under static, rather than dynamic, conditions.
Although we were generally able to retain the structural
and phenotypic characteristics of undepleted valves dur-
ing the 6-day static culture, several studies have demon-
strated differences in cellular outcomes when comparing
static to dynamic leaflet culture [34-36]. Thus, it is pos-
sible that this work would yield different results upon
exposure of the leaflets to dynamic mechanical stimula-
tion. There exist many types of valve-specific bioreactors
that differ widely in their configurations and abilities
(e.g., flow, stretch, direction of stretch, uniaxial vs. biaxial,
flexure, etc.) [34-39], but one significant caveat associated
with their use is a lack of clarity regarding what sort of
dynamic conditioning renders the most meaningful re-
sults (i.e., it is not known whether any type of mechanical
conditioning will always be more physiologically relevant
than none at all).
Conclusions
Overall, the findings presented herein emphasize the im-
portance of collagen-rich environments in maintaining a
healthy, quiescent VIC phenotype and indicate that a de-
ficiency in endogenous collagen content is sufficient to
lead to a diseased VIC phenotype and subsequent leaflet
mineralization. By successfully removing collagen from
the native ECM without impacting cellularity and tissue
structure, this work may also contribute to the goal of
creating “synthetically-diseased” leaflets that can be used
as in vitro models to study valvular disease progression
and target possible treatments. Characterizing the im-
portance of collagen in valve function may help in the
design of scaffolds for valve tissue engineering, as well as
contribute to our understanding of the events involved
in CAVD.
Additional file
Additional file 1: Figure S1. Leaflets were depleted of elastin using 20
U/mL elastase following procedures similar to those outlined for collagen
depletion. After 6 days of culture, elastin-depleted leaflets were
histologically analyzed for: (A) mineralization via von Kossa staining, (B)
α-SMA expression, and (C) ALP expression. Detectable mineralization,
α-SMA, and ALP were not found in any of the elastin-depleted leaflets.
Scale bar = 100 μm.
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